Literature DB >> 1555745

Expression of MHC class II antigens (HLA-DR, -DP, and -DQ) on human gastric epithelium.

N Ishii1, M Chiba, M Iizuka, H Watanabe, T Ishioka, O Masamune.   

Abstract

Class II antigen expression on gastric epithelium was investigated using an immunoperoxidase method in relation to the degree of inflammatory cell infiltration in the lamina propria. Sixty-six biopsy specimens from 43 patients with chronic gastritis were examined. The frequency of HLA-DR expression in specimens with cell infiltration was 94%, while that in specimens without cell infiltration was 24%. There was significant difference in the frequency of HLA-DR expression between the two groups (P less than 0.01). HLA-DR was most intensely expressed in the glandular neck portion. The frequency and extent of class II antigen expression on gastric epithelium with cell infiltration were in the following order: DR greater than DP greater than DQ. The extent of DR and DP, but not DQ expression generally paralleled the degree of cell infiltration. Intestinal metaplasia was found in 13 specimens. In the area of intestinal metaplasia, epithelial class II staining was absent except for one specimen. These results suggest that the respective genes of three class II antigens are regulated by different mechanisms and that an immunological mechanism plays a role in the pathogenesis of gastritis.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1555745     DOI: 10.1007/bf02775060

Source DB:  PubMed          Journal:  Gastroenterol Jpn        ISSN: 0435-1339


  40 in total

1.  HLA-DR antigen expression in macroscopically uninvolved areas of intestinal epithelia in Crohn's disease.

Authors:  M Chiba; M Iizuka; Y Horie; K Igarashi; O Masamune
Journal:  Gastroenterol Jpn       Date:  1989-08

2.  Expression and function of class II antigens on gastric carcinoma cells and gastric epithelia: differential expression of DR, DQ, and DP antigens.

Authors:  K Sakai; M Takiguchi; S Mori; O Kobori; Y Morioka; H Inoko; M Sekiguchi; K Kano
Journal:  J Natl Cancer Inst       Date:  1987-11       Impact factor: 13.506

3.  Occurrence of Ia antigens on tissues on non-lymphoid origin.

Authors:  K Wiman; B Curman; U Forsum; L Klareskog; U Malmnäs-Tjernlund; L Rask; L Trägårdh; P A Peterson
Journal:  Nature       Date:  1978-12-14       Impact factor: 49.962

4.  Structure and function of HLA molecules.

Authors:  E Thorsby
Journal:  Transplant Proc       Date:  1987-02       Impact factor: 1.066

5.  Immunoelectron microscopic localization of HLA-DR antigen in control small intestine and colon and in inflammatory bowel disease.

Authors:  I Hirata; L L Austin; W H Blackwell; J R Weber; W O Dobbins
Journal:  Dig Dis Sci       Date:  1986-12       Impact factor: 3.199

6.  Expression of Ia-like antigens in normal human nonlymphoid tissues.

Authors:  P G Natali; C De Martino; V Quaranta; M R Nicotra; F Frezza; M A Pellegrino; S Ferrone
Journal:  Transplantation       Date:  1981-01       Impact factor: 4.939

7.  Expression of HLA-DR antigens by colonic epithelium in inflammatory bowel disease.

Authors:  W S Selby; G Janossy; D Y Mason; D P Jewell
Journal:  Clin Exp Immunol       Date:  1983-09       Impact factor: 4.330

8.  Expression of HLA-DR antigens in inflammatory bowel disease mucosa: role of intestinal lamina propria mononuclear cell-derived interferon gamma.

Authors:  O Y Qin; M el-Youssef; B Yen-Lieberman; W Sapatnekar; K R Youngman; K Kusugami; C Fiocchi
Journal:  Dig Dis Sci       Date:  1988-12       Impact factor: 3.199

9.  Association of Campylobacter pylori with induced expression of class II transplantation antigens on gastric epithelial cells.

Authors:  L Engstrand; A Scheynius; C Påhlson; L Grimelius; A Schwan; S Gustavsson
Journal:  Infect Immun       Date:  1989-03       Impact factor: 3.441

10.  Recombinant interferon-gamma increases HLA-DR synthesis and expression.

Authors:  T Y Basham; T C Merigan
Journal:  J Immunol       Date:  1983-04       Impact factor: 5.422

View more
  6 in total

1.  CagA-dependent downregulation of B7-H2 expression on gastric mucosa and inhibition of Th17 responses during Helicobacter pylori infection.

Authors:  Taslima T Lina; Irina V Pinchuk; Jennifer House; Yoshio Yamaoka; David Y Graham; Ellen J Beswick; Victor E Reyes
Journal:  J Immunol       Date:  2013-08-30       Impact factor: 5.422

2.  Role of gastric epithelial cell-derived transforming growth factor beta in reduced CD4+ T cell proliferation and development of regulatory T cells during Helicobacter pylori infection.

Authors:  Ellen J Beswick; Iryna V Pinchuk; Rachel B Earley; David A Schmitt; Victor E Reyes
Journal:  Infect Immun       Date:  2011-04-11       Impact factor: 3.441

Review 3.  Immune evasion strategies used by Helicobacter pylori.

Authors:  Taslima T Lina; Shatha Alzahrani; Jazmin Gonzalez; Irina V Pinchuk; Ellen J Beswick; Victor E Reyes
Journal:  World J Gastroenterol       Date:  2014-09-28       Impact factor: 5.742

4.  Expression of the programmed death ligand 1, B7-H1, on gastric epithelial cells after Helicobacter pylori exposure promotes development of CD4+ CD25+ FoxP3+ regulatory T cells.

Authors:  Ellen J Beswick; Irina V Pinchuk; Soumita Das; Don W Powell; Victor E Reyes
Journal:  Infect Immun       Date:  2007-06-11       Impact factor: 3.441

5.  Topographic study of Helicobacter pylori and HLA-DR antigen expression on gastric epithelium.

Authors:  M Chiba; N Ishii; T Ishioka; M Murata; O Masamune; T Sugiyama; A Yachi
Journal:  J Gastroenterol       Date:  1995-04       Impact factor: 7.527

6.  HLA Ligand Atlas: a benign reference of HLA-presented peptides to improve T-cell-based cancer immunotherapy.

Authors:  Ana Marcu; Leon Bichmann; Leon Kuchenbecker; Daniel Johannes Kowalewski; Lena Katharina Freudenmann; Linus Backert; Lena Mühlenbruch; András Szolek; Maren Lübke; Philipp Wagner; Tobias Engler; Sabine Matovina; Jian Wang; Mathias Hauri-Hohl; Roland Martin; Konstantina Kapolou; Juliane Sarah Walz; Julia Velz; Holger Moch; Luca Regli; Manuela Silginer; Michael Weller; Markus W Löffler; Florian Erhard; Andreas Schlosser; Oliver Kohlbacher; Stefan Stevanović; Hans-Georg Rammensee; Marian Christoph Neidert
Journal:  J Immunother Cancer       Date:  2021-04       Impact factor: 13.751

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.